Want to join the conversation?
$REGN 2Q15 Call: Based on the strong US EYLEA net sales in 2Q15, the company is increasing its full year US EYLEA net sales guidance to be YoverY growth of between 45-50% from the previously provided range of 30-35%. Recently announced a major collaboration with Sanofi in immuno-oncology.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.